To assess the relative and absolute risks of liver injury following exposure to flucloxacillin and identify subgroups at potentially increased risk” Wing et al (2017).
Background: Flucloxacillin is an established cause of liver injury. Despite this, there are a lack of published data on both the strength of association after adjusting for potential confounders, and the absolute incidence among different subgroups of patients.
ReTweet if useful… What is the risk of liver injury associated with flucloxacillin? https://ctt.ec/mD2tE+ @ivteam #ivteam
Objectives: To assess the relative and absolute risks of liver injury following exposure to flucloxacillin and identify subgroups at potentially increased risk.
Methods: A cohort study between 1 January 2000 and 1 January 2012 using the UK Clinical Practice Research Datalink, including 1 046 699 people with a first prescription for flucloxacillin (861 962) or oxytetracycline (184 737). Absolute risks of experiencing both symptom-defined (jaundice) and laboratory-confirmed liver injury within 1–45 and 46–90 days of antibiotic initiation were estimated. Multivariable logistic regression was used to estimate 1–45 day relative effects.
Results: There were 183 symptom-defined cases (160 prescribed flucloxacillin) and 108 laboratory-confirmed cases (102 flucloxacillin). The 1–45 day adjusted risk ratio for laboratory-confirmed injury was 5.22 (95% CI 1.64–16.62) comparing flucloxacillin with oxytetracycline use. The 1–45 day risk of laboratory-confirmed liver injury was 8.47 per 100 000 people prescribed flucloxacillin (95% CI 6.64–10.65). People who received consecutive flucloxacillin prescriptions had a 1–45 day risk of jaundice of 39.00 per 100 000 (95% CI 26.85–54.77), while those aged >70 receiving consecutive prescriptions had a risk of 110.57 per 100 000 (95% CI 70.86–164.48).
Conclusions: The short-term risk of laboratory-confirmed liver injury was >5-fold higher after a flucloxacillin prescription than an oxytetracycline prescription. The risk of flucloxacillin-induced liver injury is particularly high within those aged >70 and those who receive multiple flucloxacillin prescriptions. The stratified risk estimates from this study could help guide clinical care.
Wing, K., Bhaskaran, K., Pealing, L., Root, A., Smeeth, L., van Staa, T.P., Klungel, O.H., Reynolds, R.F. and Douglas, I. (2017) Quantification of the risk of liver injury associated with flucloxacillin: a UK population-based cohort study. Journal of Antimicrobial Chemotherapy. 72(9), p.2636–2646.
Thank you to our partners for supporting IVTEAM